These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 8299722)

  • 1. Enhancement of CDDP cytotoxicity by caffeine is characterized by apoptotic cell death.
    Shinomiya N; Shinomiya M; Wakiyama H; Katsura Y; Rokutanda M
    Exp Cell Res; 1994 Feb; 210(2):236-42. PubMed ID: 8299722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine induces S-phase apoptosis in cis-diamminedichloroplatinum-treated cells, whereas cis-diamminedichloroplatinum induces a block in G2/M.
    Shinomiya N; Takemura T; Iwamoto K; Rokutanda M
    Cytometry; 1997 Apr; 27(4):365-73. PubMed ID: 9098629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
    Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of CDDP cytotoxicity by caffeine is characterized by apoptotic cell death.
    Takahashi M; Yamamoto Y; Hatori S; Shiozawa M; Suzuki M; Rino Y; Amano T; Imada T
    Oncol Rep; 1998; 5(1):53-6. PubMed ID: 9458292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.
    Xie XK; Yang DS; Ye ZM; Tao HM
    Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.
    Qamar L; Davis R; Anwar A; Behbakht K
    Gynecol Oncol; 2008 Sep; 110(3):425-31. PubMed ID: 18619662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine and staurosporine enhance the cytotoxicity of cisplatin and camptothecin in human brain tumor cell lines.
    Janss AJ; Levow C; Bernhard EJ; Muschel RJ; McKenna WG; Sutton L; Phillips PC
    Exp Cell Res; 1998 Aug; 243(1):29-38. PubMed ID: 9716446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronidazole enhances the cytotoxic synergism produced by the combination of 1-beta-arabinofuranosylcytosine and cis-diamminedichloroplatinum.
    Trujillo JM; Yang LY; Gercovich G; Su YZ; Lee J
    Anticancer Res; 1989; 9(6):1751-6. PubMed ID: 2627125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.
    Light BW; Yu WD; McElwain MC; Russell DM; Trump DL; Johnson CS
    Cancer Res; 1997 Sep; 57(17):3759-64. PubMed ID: 9288784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor.
    Halicka HD; Ardelt B; Li X; Melamed MM; Darzynkiewicz Z
    Cancer Res; 1995 Jan; 55(2):444-9. PubMed ID: 7812976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
    Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G
    Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivity.
    Donato NJ; Perez M; Kang H; Siddik ZH; Ling YH; Perez-Soler R
    Clin Cancer Res; 2000 Jan; 6(1):193-202. PubMed ID: 10656450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM.
    Lin CK; Nguyen TT; Morgan TL; Mei RL; Kaptein JS; Kalunta CI; Yen CF; Park E; Zou HY; Lad PM
    Exp Cell Res; 1998 Oct; 244(1):1-13. PubMed ID: 9770343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of cytocidal and antitumor effect of cisplatin by caffeine in human osteosarcoma.
    Tomita K; Tsuchiya H
    Clin Ther; 1989; 11(1):43-52. PubMed ID: 2720727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of caffeine on potentially lethal damage repair in cisplatin-treated human osteosarcoma cells.
    Yasutake H; Tsuchiya H; Tomita K; Matsunaga T; Nikaido O; Mori T
    Anticancer Res; 1995; 15(3):831-7. PubMed ID: 7645967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined effect of cisplatin and caffeine on murine B16-BL6 melanoma cells].
    Yasutake H; Tsuchiya H; Sugihara M; Tomita K; Ueda Y; Tanaka M; Sasaki T
    Gan To Kagaku Ryoho; 1989 May; 16(5):2031-8. PubMed ID: 2730093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Enhanced effect of intraperitoneal administration of CDDP combined with caffeine against peritoneal metastasis].
    Yamamoto Y; Amano T; Imada T; Akaike M; Noguchi Y; Aoyama N; Tsuburaya A; Rino Y; Takehana T; Hasuo K
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1825-31. PubMed ID: 1877825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.
    Esaki T; Nakano S; Tatsumoto T; Kuroki-Migita M; Mitsugi K; Nakamura M; Niho Y
    Cancer Res; 1992 Dec; 52(23):6501-6. PubMed ID: 1423296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokinetic and morphologic differences in ovarian cancer cells treated with ET-18-OCH3 and the DNA-interacting agent, etoposide.
    Fujiwara K; Koike H; Ohishi Y; Shirafuji H; Kohno I; Modest EJ; Kataoka S
    Anticancer Res; 1997; 17(3C):2159-67. PubMed ID: 9216681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.